サマリー

クラッベ病治療の世界市場 2022-2026 年
Technavioは、クラッベ病治療市場を監視しており、2022-2026年の間に43803万ドル、予測期間中にCAGR7.56%で加速して成長する見込みであるとしています。当レポートでは、クラッベ病治療市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、特効薬指定、アンメットクリニカルニーズ、血族婚の慣習によって牽引されています。
クラッベ病治療市場の分析には、治療区分と地理的状況も含まれます。
Technavioのクラッベ病治療市場は、以下のように区分されています。
治療法別
- 抗けいれん剤
- 筋弛緩剤
- 造血幹細胞移植
- その他
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、薬理学的シャペロン療法の出現が、今後数年間のクラッベ病治療市場の成長を促進する主要な理由の一つであると特定しています。また、治療における遺伝子技術やクラッベ病に関する認知度の向上も、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当レポートでは、クラッベ病治療市場について、以下の内容をご紹介します。
- クラッベ病治療薬市場のサイジング
- クラッベ病治療市場予測
- クラッベ病治療市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Acorda Therapeutics Inc.、CENTOGENE NV、GlaxoSmithKline Plc、Johnson and Johnson、Novartis AG、Pfizer Inc、Polarix、Teva Pharmaceutical Industries Ltd、UCB SAといった複数の主要クラッベ病治療のベンダーに関する詳細分析を提供しています。また、クラッベ病治療市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/krabbe-disease-treatment-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Therapy
o 5.1 Market segments
o Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
o 5.2 Comparison by Therapy
o Exhibit 26: Chart on Comparison by Therapy
o Exhibit 27: Data Table on Comparison by Therapy
o 5.3 Anticonvulsants - Market size and forecast 2021-2026
o Exhibit 28: Chart on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Anticonvulsants - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Anticonvulsants - Year-over-year growth 2021-2026 (%)
o 5.4 Muscle relaxants - Market size and forecast 2021-2026
o Exhibit 32: Chart on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Muscle relaxants - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Muscle relaxants - Year-over-year growth 2021-2026 (%)
o 5.5 HSCT - Market size and forecast 2021-2026
o Exhibit 36: Chart on HSCT - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on HSCT - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on HSCT - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on HSCT - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Therapy
o Exhibit 44: Market opportunity by Therapy ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share by geography 2021-2026 (%)
o Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 China - Market size and forecast 2021-2026
o Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity by geography
o Exhibit 90: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 97: AbbVie Inc. - Overview
o Exhibit 98: AbbVie Inc. - Product / Service
o Exhibit 99: AbbVie Inc. - Key offerings
o 10.4 Acorda Therapeutics Inc.
o Exhibit 100: Acorda Therapeutics Inc. - Overview
o Exhibit 101: Acorda Therapeutics Inc. - Business segments
o Exhibit 102: Acorda Therapeutics Inc. - Key offerings
o Exhibit 103: Acorda Therapeutics Inc. - Segment focus
o 10.5 CENTOGENE NV
o Exhibit 104: CENTOGENE NV - Overview
o Exhibit 105: CENTOGENE NV - Key offerings
o 10.6 GlaxoSmithKline Plc
o Exhibit 106: GlaxoSmithKline Plc - Overview
o Exhibit 107: GlaxoSmithKline Plc - Business segments
o Exhibit 108: GlaxoSmithKline Plc - Key news
o Exhibit 109: GlaxoSmithKline Plc - Key offerings
o Exhibit 110: GlaxoSmithKline Plc - Segment focus
o 10.7 Johnson and Johnson
o Exhibit 111: Johnson and Johnson - Overview
o Exhibit 112: Johnson and Johnson - Business segments
o Exhibit 113: Johnson and Johnson - Key news
o Exhibit 114: Johnson and Johnson - Key offerings
o Exhibit 115: Johnson and Johnson - Segment focus
o 10.8 Novartis AG
o Exhibit 116: Novartis AG - Overview
o Exhibit 117: Novartis AG - Business segments
o Exhibit 118: Novartis AG - Key offerings
o Exhibit 119: Novartis AG - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 120: Pfizer Inc. - Overview
o Exhibit 121: Pfizer Inc. - Product / Service
o Exhibit 122: Pfizer Inc. - Key news
o Exhibit 123: Pfizer Inc. - Key offerings
o 10.10 Polaryx
o Exhibit 124: Polaryx - Overview
o Exhibit 125: Polaryx - Product / Service
o Exhibit 126: Polaryx - Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 127: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 128: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 130: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 131: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 UCB SA
o Exhibit 132: UCB SA - Overview
o Exhibit 133: UCB SA - Product / Service
o Exhibit 134: UCB SA - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 135: Inclusions checklist
o Exhibit 136: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 137: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 138: Research methodology
o Exhibit 139: Validation techniques employed for market sizing
o Exhibit 140: Information sources
o 11.5 List of abbreviations
o Exhibit 141: List of abbreviations
o


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapy
Exhibits27: Data Table on Comparison by Therapy
Exhibits28: Chart on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Anticonvulsants - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Anticonvulsants - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Muscle relaxants - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Muscle relaxants - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on HSCT - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on HSCT - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on HSCT - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on HSCT - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Therapy ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share by geography 2021-2026 (%)
Exhibits47: Data Table on Market share by geography 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity by geography ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: AbbVie Inc. - Overview
Exhibits98: AbbVie Inc. - Product / Service
Exhibits99: AbbVie Inc. - Key offerings
Exhibits100: Acorda Therapeutics Inc. - Overview
Exhibits101: Acorda Therapeutics Inc. - Business segments
Exhibits102: Acorda Therapeutics Inc. - Key offerings
Exhibits103: Acorda Therapeutics Inc. - Segment focus
Exhibits104: CENTOGENE NV - Overview
Exhibits105: CENTOGENE NV - Key offerings
Exhibits106: GlaxoSmithKline Plc - Overview
Exhibits107: GlaxoSmithKline Plc - Business segments
Exhibits108: GlaxoSmithKline Plc - Key news
Exhibits109: GlaxoSmithKline Plc - Key offerings
Exhibits110: GlaxoSmithKline Plc - Segment focus
Exhibits111: Johnson and Johnson - Overview
Exhibits112: Johnson and Johnson - Business segments
Exhibits113: Johnson and Johnson - Key news
Exhibits114: Johnson and Johnson - Key offerings
Exhibits115: Johnson and Johnson - Segment focus
Exhibits116: Novartis AG - Overview
Exhibits117: Novartis AG - Business segments
Exhibits118: Novartis AG - Key offerings
Exhibits119: Novartis AG - Segment focus
Exhibits120: Pfizer Inc. - Overview
Exhibits121: Pfizer Inc. - Product / Service
Exhibits122: Pfizer Inc. - Key news
Exhibits123: Pfizer Inc. - Key offerings
Exhibits124: Polaryx - Overview
Exhibits125: Polaryx - Product / Service
Exhibits126: Polaryx - Key offerings
Exhibits127: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits128: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits129: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits130: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits131: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits132: UCB SA - Overview
Exhibits133: UCB SA - Product / Service
Exhibits134: UCB SA - Key offerings
Exhibits135: Inclusions checklist
Exhibits136: Exclusions checklist
Exhibits137: Currency conversion rates for US$
Exhibits138: Research methodology
Exhibits139: Validation techniques employed for market sizing
Exhibits140: Information sources
Exhibits141: List of abbreviations